| Source: The Associated Press
The board of Czech generic drugs maker Zentiva N.V. said Friday it has recommended that its shareholders reject a takeover offer from French pharmaceuticals maker Sanofi-Aventis SA.
| Source: The Associated Press
Shares of Gilead Sciences Inc. fell sharply Friday as Wall Street viewed the drug developer's latest earnings report as sign that the company could be shifting to a more subdued level of growth as its HIV treatments saturate the market.
| Source: The Associated Press
Life sciences company MDS Inc. said Friday it will cut about 210 jobs at its MDS Pharma Services and MDS Analytical Technologies divisions to reduce costs, and write down the value of a Canadian facility.
| Source: The Associated Press
Molecular diagnostics company Celera Corp. said Friday the Food and Drug Administration approved new system software used for HIV monitoring and treatment.
| Source: The Associated Press
Among the premarket stories for Friday, July 18, from AP Financial News:
| Source: The Associated Press
Teva Pharmaceutical will buy rival generic drug company Barr Pharmaceuticals in a move that will boost Teva’s dominance as the world’s biggest generic drugmaker.
| Source: The Associated Press
The Food and Drug Administration has unveiled a plan for recruiting young staffers to replace the hundreds of scientists retiring from the agency.
| Source: The Associated Press
Covidien Ltd. said its board declared a quarterly cash dividend of 16 cents.
| Source: The Associated Press
Thousands of Californians who lost their health coverage after filing claims with their insurance companies are about to get their policies restored.
Thursday, 17 Jul 2008 | Source: The Associated Press
A jury refused to award damages Thursday to a couple who sued drug maker Johnson & Johnson for $1 billion, claiming its Children's Motrin nearly killed their daughter and left her legally blind.
Thursday, 17 Jul 2008 | Source: The Associated Press
Shares of biotechnology giant Genentech Inc. rose Thursday as a Citi analyst pointed to the sales potential for the cancer treatment Avastin as a reason to own the stock.
Thursday, 17 Jul 2008 | Source: The Associated Press
Shares of Baxter International rose to an all-time high Thursday after the company reported earnings that beat Wall Street expectations, due to higher sales of biotech drugs and vaccines.
Thursday, 17 Jul 2008 | Source: The Associated Press
Strong sales of biotech drugs and vaccines drove second-quarter profit up 26 percent for drugs and medical device maker Baxter International Inc., beating Wall Street estimates.
Thursday, 17 Jul 2008 | Source: The Associated Press
Among the earnings stories for Thursday, July 17, from AP Financial News:
Thursday, 17 Jul 2008 | Source: The Associated Press
Among the earnings stories for Thursday, July 17, from AP Financial News: